Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer, which is the leading cause of cancer-related deaths worldwide. Over the past decades, tumour angiogenesis has been intensely studied in the treatment of NSCLC due to its fundamental role in cancer progression. Several anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Charnay, Bolcaen, Julie, Bisio, Alessandra, Genis, Amanda, Strijdom, Hans, Vandevoorde, Charlot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961924/
https://www.ncbi.nlm.nih.gov/pubmed/37259367
http://dx.doi.org/10.3390/ph16020219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961924/
https://www.ncbi.nlm.nih.gov/pubmed/37259367
http://dx.doi.org/10.3390/ph16020219

Ejemplares similares